119 related articles for article (PubMed ID: 36854520)
1. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer.
Kano MT; Kokuryo T; Baba T; Yamazaki K; Yamaguchi J; Sunagawa M; Ogura A; Watanabe N; Onoe S; Miyata K; Mizuno T; Uehara K; Igami T; Yokoyama Y; Ebata T; Nagino M
Anticancer Res; 2023 Mar; 43(3):1009-1016. PubMed ID: 36854520
[TBL] [Abstract][Full Text] [Related]
2. α-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson's disease.
Javed H; Meeran MFN; Azimullah S; Bader Eddin L; Dwivedi VD; Jha NK; Ojha S
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33049992
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.
Huanwen W; Zhiyong L; Xiaohua S; Xinyu R; Kai W; Tonghua L
Mol Cancer; 2009 Dec; 8():125. PubMed ID: 20021699
[TBL] [Abstract][Full Text] [Related]
4. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of α-bisabolol against pancreatic cancer.
Seki T; Kokuryo T; Yokoyama Y; Suzuki H; Itatsu K; Nakagawa A; Mizutani T; Miyake T; Uno M; Yamauchi K; Nagino M
Cancer Sci; 2011 Dec; 102(12):2199-205. PubMed ID: 21883695
[TBL] [Abstract][Full Text] [Related]
6. α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation.
Uno M; Kokuryo T; Yokoyama Y; Senga T; Nagino M
Anticancer Res; 2016 Feb; 36(2):583-9. PubMed ID: 26851012
[TBL] [Abstract][Full Text] [Related]
7. The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
Kurenova E; Liao J; He DH; Hunt D; Yemma M; Bshara W; Seshadri M; Cance WG
Oncotarget; 2013 Oct; 4(10):1632-46. PubMed ID: 24142503
[TBL] [Abstract][Full Text] [Related]
8. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
9. Phase solubility studies of pure (-)-alpha-bisabolol and camomile essential oil with beta-cyclodextrin.
Waleczek KJ; Marques HM; Hempel B; Schmidt PC
Eur J Pharm Biopharm; 2003 Mar; 55(2):247-51. PubMed ID: 12637105
[TBL] [Abstract][Full Text] [Related]
10. α-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3.
Fang D; Wang H; Li M; Wei W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31127027
[TBL] [Abstract][Full Text] [Related]
11. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.
Pathania D; Kuang Y; Sechi M; Neamati N
Br J Pharmacol; 2015 Jan; 172(1):50-63. PubMed ID: 25047070
[TBL] [Abstract][Full Text] [Related]
13. BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes.
Rigo A; Ferrarini I; Lorenzetto E; Darra E; Liparulo I; Bergamini C; Sissa C; Cavalieri E; Vinante F
Cell Death Dis; 2019 Nov; 10(12):889. PubMed ID: 31767857
[TBL] [Abstract][Full Text] [Related]
14. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.
Hochwald SN; Nyberg C; Zheng M; Zheng D; Wood C; Massoll NA; Magis A; Ostrov D; Cance WG; Golubovskaya VM
Cell Cycle; 2009 Aug; 8(15):2435-43. PubMed ID: 19571674
[TBL] [Abstract][Full Text] [Related]
15. The antineoplastic agent α-bisabolol promotes cell death by inducing pores in mitochondria and lysosomes.
Rigo A; Vinante F
Apoptosis; 2016 Aug; 21(8):917-27. PubMed ID: 27278818
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.
Moen I; Gebre M; Alonso-Camino V; Chen D; Epstein D; McDonald DM
Clin Exp Metastasis; 2015 Dec; 32(8):799-817. PubMed ID: 26445848
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Scolicidal Activity of the Sesquiterpenes Isofuranodiene, α-Bisabolol and Farnesol on
Youssefi MR; Nikpay A; Hassanpour N; Mirzapour A; Tabari PS; Pavela R; Maggi F; Petrelli R
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784679
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.
Ucar DA; Magis AT; He DH; Lawrence NJ; Sebti SM; Kurenova E; Zajac-Kaye M; Zhang J; Hochwald SN
Anticancer Agents Med Chem; 2013 May; 13(4):595-602. PubMed ID: 23272972
[TBL] [Abstract][Full Text] [Related]
20. Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent.
Rigo A; Ferrarini I; Bonalumi A; Tecchio C; Montresor A; Laudanna C; Vinante F
Oncotarget; 2018 May; 9(40):25877-25890. PubMed ID: 29899828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
